Indoco Cures’s wholly-owned subsidiary, Warren Cures Pvt Ltd, has commenced business manufacturing of pharmaceutical intermediates and lively pharmaceutical substances (APIs) at its greenfield manufacturing facility at Aurangabad, Maharashtra.
Aditi Panandikar, Managing Director, Indoco Cures Ltd stated, “The manufacturing facility will present us the requisite capabilities and edge in assembly the demand of APIs.”
Indoco Cures inventory closed at ₹337 on the NSE, up 0.18 per cent on Friday’s commerce.
The corporate’s board lately permitted the acquisition of land admeasuring 2,860.75 sq. meters at Mahal Industrial Property, Village Mulgaon, Taluka Andheri, Mumbai, from Saldanha Realty and Infrastructure LLP for the enlargement plans.
#Indoco #Cures #subsidiary #commences #manufacturing #pharmaceutical #intermediates